Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | ABL1 | P00519 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | IDE | P14735 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | HLCS | P50747 | 6/20 | 0.54 |
| ▸ | CA12 | O43570 | 7/20 | 0.48 |
| ▸ | CA1 | P00915 | 7/20 | 0.48 |
| ▸ | CA2 | P00918 | 7/20 | 0.48 |
| ▸ | CA9 | Q16790 | 7/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23066879 | 1.00 | TDP1 (0.62) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL912652 | 0.91 | TDP1 (0.74) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL15647842 | 0.90 | TDP1 (0.77) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL2536441 | 0.89 | TDP1 (0.62) | TDP1MEN1ABL1LMNAPKM | |
| Hydrochloric Acid SCHEMBL3417755 | 0.88 | TDP1 (0.61) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL6040739 | 0.86 | TDP1 (0.67) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL20417372 | 0.85 | TDP1 (0.85) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL12372458 | 0.85 | TDP1 (0.85) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL28084581 | 0.85 | TDP1 (0.69) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL23745168 | 0.85 | TDP1 (0.85) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9981044-B2 | Activation of adaptive immune processes for the treatment of cancers and infectious diseases | SUSAVION BIOSCIENCES, INC. (US) | 2018-05-29 | — | — | US | disclosed |
| US-20170290922-A1 | ACTIVATION OF ADAPTIVE IMMUNE PROCESSES FOR THE TREATMENT OF CANCERS AND INFECTIOUS DISEASES | SUSAVION BIOSCIENCES, INC. | 2017-10-12 | — | — | US | disclosed |
| WO-2016033602-A1 | ACTIVATION OF ADAPTIVE IMMUNE PROCESSES FOR THE TREATMENT OF CANCERS AND INFECTIOUS DISEASES | SUSAVION BIOSCIENCES, INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| US-20150299252-A1 | COMPOSITIONS AND METHODS FOR MODULATING INNATE AND ADAPTIVE IMMUNE SYSTEMS | SUSAVION BIOSCIENCES, INC. (US) | 2015-10-22 | — | — | US | disclosed |
| US-20150299255-A1 | COMPOSITIONS AND METHODS FOR MODULATING INNATE AND ADAPTIVE IMMUNE SYSTEMS | SUSAVION BIOSCIENCES, INC. | 2015-10-22 | — | — | US | disclosed |
| WO-2013096829-A2 | ACTIVATION OF CELLULAR ASSAULT PROCESSES IN THE TREATMENT OF GLIOBLASTOMA MULTIFORME | ARIZONA BIOMEDICAL RESEARCH COMMISSION (US) | 2013-06-27 | — | — | WO | disclosed |